Second, semaglutide activates GLP-1 receptors in the central nervous system, particularly in the brainstem area postrema and nucleus tractus solitarius, regions responsible for nausea and vomiting responses
Glucagon-like peptide-1 (GLP-1) receptor agonistssometimes called incretin mimeticsare a class of medications shown to be effective in managing type 2 diabetes as well as in treating individuals with obesity or overweight
ALA: Alpha-Linolenic Acid,GPX4: Glutathione Peroxidase 4, GSH: glutathione, CISD2: CDGSH, Iron Sulfur Domain 2, SLC7A11: Solute Carrier Family 7 Member 11, IGF2BP3: Insulin-Like Growth Factor 2 mRNA, Binding Protein 3, RM: Recurrent miscarriage, EMT: Epithelial-Mesenchymal Transition, HIF1: Hypoxia-Inducible Factor 1 Alpha, lnc-HZ06: Long Non-coding RNA HZ06, NCOA4: Nuclear Receptor Coactivator 4, lncRNA: Long Non-coding RNA, ROS: reactive oxygen species, TP53: Tumor Protein 53, EZH2: Enhancer of Zeste Homolog 2, TIMP1: Tissue inhibitor matrix metalloproteinase 1, SLC3A2: Solute Carrier Family 3 Member 2, GABARAPL2: Gamma-aminobutyric acid receptor-associated protein-like 2
By modifying all these metabolic pathways, semaglutide benefits restore a more stable metabolic state, which is disturbed in situations like type 2 diabetes and obesity
Each wave is part of the process
In humans, the concern is focused on medullary thyroid carcinoma, which is rare and biologically distinct from the more common papillary and follicular thyroid cancers